Mesothelioma Blog, Important Mesothelioma Research and information
Search
27th September 2005 : Onconase - Turning programmed cell death back on ...The company Alfacell has been conducting phase IIIb trials with a new drug called Onconase for use in malignant mesothelioma. One of the problems with cancer cells is that they have lost the ability to self-destruct when they are genetically damaged. This allows a damages cell to keep dividing and...  This article is courtesy of Mesothelioma Research and Information Mesothelioma Tests - A Breakthrough | Mesothelioma Staging - The Knowledge IV | U.K. Lawyer Wants Public Funds Used in Asbestos Claims 
Categories: Mesothelioma Articles |
|
||||||
